chr1-167683939-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052862.4(RCSD1):c.46G>A(p.Ala16Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052862.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RCSD1 | NM_052862.4 | c.46G>A | p.Ala16Thr | missense_variant | 2/7 | ENST00000367854.8 | NP_443094.3 | |
RCSD1 | NM_001322923.2 | c.46G>A | p.Ala16Thr | missense_variant | 2/6 | NP_001309852.1 | ||
RCSD1 | NM_001322924.2 | c.46G>A | p.Ala16Thr | missense_variant | 2/5 | NP_001309853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RCSD1 | ENST00000367854.8 | c.46G>A | p.Ala16Thr | missense_variant | 2/7 | 1 | NM_052862.4 | ENSP00000356828 | P2 | |
RCSD1 | ENST00000537350.5 | c.46G>A | p.Ala16Thr | missense_variant | 2/6 | 1 | ENSP00000439409 | A2 | ||
RCSD1 | ENST00000361496.3 | c.46G>A | p.Ala16Thr | missense_variant | 2/5 | 3 | ENSP00000355291 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727236
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.46G>A (p.A16T) alteration is located in exon 2 (coding exon 2) of the RCSD1 gene. This alteration results from a G to A substitution at nucleotide position 46, causing the alanine (A) at amino acid position 16 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at